Therapeutic Enoxaparin Dosing in Obesity
M Appay, S Kharadi, S Nanayakkara… - Annals of …, 2024 - journals.sagepub.com
Objective: This review aims to systematically summarize the available data on efficacy and
safety of therapeutic enoxaparin in obese patients and to identify gaps to guide future …
safety of therapeutic enoxaparin in obese patients and to identify gaps to guide future …
Venous thrombosis and obesity: from clinical needs to therapeutic challenges
F La Rosa, F Montecucco, L Liberale… - Internal and Emergency …, 2024 - Springer
Weight bias and stigma have limited the awareness of the systemic consequences related to
obesity. As the narrative evolves, obesity is emerging as a driver and enhancer of many …
obesity. As the narrative evolves, obesity is emerging as a driver and enhancer of many …
Risk Stratification for Supratherapeutic Peak Anti-Xa Levels in Adult Patients on Therapeutic Enoxaparin
SA Sheredy, AC Stone… - Annals of …, 2024 - journals.sagepub.com
Background: The American Society of Hematology Guidelines for the management of
venous thromboembolism recommend against the use of anti-Xa monitoring for assessing …
venous thromboembolism recommend against the use of anti-Xa monitoring for assessing …
Factors associated with venous thromboembolic disease due to failed thromboprophylaxis
SG Pérez, P Ruiz-Talero, OMM Velandia - Thrombosis Journal, 2023 - Springer
Introduction Available evidence to identify factors independently associated with failed
thromboprophylaxis (FT) in medical patients is insufficient. The present study seeks to …
thromboprophylaxis (FT) in medical patients is insufficient. The present study seeks to …
Primary prevention of venous thromboembolism with low molecular weight heparins in surgical patients–2024: Council of Experts resolution
АS Petrikov, ТV Vavilova… - …, 2024 - pharmacoeconomics.ru
Abstract On March 15, 2024, in Moscow, the Russian Phlebological Association and the
National Association of Specialists in Thrombosis, Clinical Hemostasiology and …
National Association of Specialists in Thrombosis, Clinical Hemostasiology and …
Factors associated with the development of venous thromboembolic disease due to failed thromboprophylaxis.
SG Perez, PAR Talero, OMM Velandia - 2023 - researchsquare.com
Introduction: Available evidence to identify factors independently associated with failed
thromboprophylaxis (FT) in medical patients is insufficient. The present study seeks to …
thromboprophylaxis (FT) in medical patients is insufficient. The present study seeks to …
[PDF][PDF] Doporučené dávkování antikoagulancií v době pandemie obezity
A Pilková - Vnitřní lékařství, 2024 - casopisvnitrnilekarstvi.cz
Anticoagulants are an important therapeutic group of drugs used in the prevention and
treatment of thromboembolic disease. Despite their widespread use, many questions remain …
treatment of thromboembolic disease. Despite their widespread use, many questions remain …